Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

FDA approves new AI-enabled wearable cardioverter defibrillator
The newly approved device can be worn for up to a week at a time, with no daily maintenance required, and includes advanced AI algorithms that minimize the risk of false alarms or inappropriate shocks.
Cardiologists share late-breaking TAVR data on first day of SCAI 2025
New TAVR data on SAPT vs. DAPT and prosthesis-patient mismatch among women were some of the many highlights of the conference's opening day.
Latest EARLY TAVR data suggest it is time to update industry guidelines
Philippe Genereux, MD, principal investigator of EARLY TAVR, presented new data at ACC.25 showing intervening early on crossover patients with asymptomatic severe aortic stenosis led to better outcomes and a reduced stroke rate.
A victory for early treatment: FDA approves first TAVR valves for asymptomatic severe aortic stenosis
The FDA has approved the balloon-expandable Sapien 3 TAVR platform from Edwards Lifesciences for treating asymptomatic severe aortic stenosis. This is the first time the agency has approved any TAVR technology to be used in asymptomatic patients.
Focal ablation yields lower treatment failure rates than surgery for prostate cancer
This is the first randomized controlled trial to compare the use of ultrasound energy-based focal ablation to robot-assisted radical prostatectomy.

Keto-like diets linked to increased risk of high cholesterol, heart disease

New research, presented during ACC.23/WCC in New Orleans, has raised fresh concerns about the potential cardiovascular-related drawbacks of high-fat, low-carbohydrate diets.

Atul Verma, MD, head of cardiology at McGill University Health Centre

Day 3 at ACC.23 features late-breaking studies on pulsed-field ablation, other new technologies

The third and final day of ACC.23 featured a key update on Medtronic's pulsed-field ablation technology and many other late-breaking clinical studies.

Infertility linked to a higher risk of coronary heart disease

The associations were strongest for women who experienced infertility at the age of 25 or younger.

ACC 2023 ACC.23 American College of Cardiology

Day 2 at ACC.23 features late-breaking studies on TEER, TAVR, EHR alerts and much more

Catch up on the biggest news that came out of the second day of ACC.23 in New Orleans.

ACC.23 Together with the World Congress of Cardiology

Day 1 at ACC.23 features late-breaking studies on bempedoic acid, tricuspid valve repair and statins

The conference kicked off with three late-breaking studies that could have a huge impact on patient care going forward.

Large study finds high rates of nonadherence to statin recommendations; women especially averse

Many patients who would clearly benefit by lowered LDL cholesterol levels are choosing to forgo first-time recommendations for statin regimens, according to a population-level study.

PCI with a DES: Comparing 10-year outcomes between men and women

One key takeaway was that women faced a higher MI risk than men, but only for the first 30 days.

Low BMI increases risk of cardiac tamponade during AFib ablation

Also, researchers noted, cryoballoon ablation was linked to a lower risk of cardiac tamponade than radiofrequency ablation. The study included data from nearly 60,000 hospitalizations.

Clinical

FDA approves new AI-enabled wearable cardioverter defibrillator

Cardiologists share late-breaking TAVR data on first day of SCAI 2025

Latest EARLY TAVR data suggest it is time to update industry guidelines

A victory for early treatment: FDA approves first TAVR valves for asymptomatic severe aortic stenosis

Focal ablation yields lower treatment failure rates than surgery for prostate cancer